Family Practice NewsIcosapent ethyl cost effective in REDUCE-IT analysisDecember 2, 2019CardiologyPreventive Care
Family Practice NewsDAPA-HF: Dapagliflozin benefits regardless of age, HF severityNovember 25, 2019CardiologyDiabetesEndocrinology
Family Practice NewsLarge population-based study underscores link between gout, CVD event riskNovember 23, 2019RheumatologyCardiology
Family Practice NewsData build on cardiovascular disease risk after GDM, HDPNovember 20, 2019Women's HealthCardiologyDiabetesPreventive Care
Family Practice NewsDAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabeticsNovember 17, 2019DiabetesCardiologyEndocrinology
Family Practice NewsFDA panel supports Vascepa expanded indication for CVD reductionNovember 14, 2019Preventive CareCardiologyEndocrinology
Family Practice NewsFDA still concerned about biotin affecting troponin testsNovember 12, 2019Mixed TopicsCardiology
Family Practice NewsStatins cut long-term CVD risk in kids with familial hypercholesterolemiaNovember 11, 2019Cardiology
Family Practice NewsLow LDL-C and blood pressure can reduce lifetime CVD risk by 80%November 11, 2019Preventive CareCardiology
Family Practice NewsCVD risk in black SLE patients 18 times higher than in whitesNovember 11, 2019RheumatologyCardiology
Family Practice NewsGetting high heightens stroke, arrhythmia risksNovember 11, 2019PulmonologyCardiology
